Fatal evolution of acute Chagas disease in a child from Northern Brazil: factors that determine poor prognosis

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2019
Editora
INST MEDICINA TROPICAL SAO PAULO
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Métricas da Revista
Autores
ESPER, Helena Rangel
ASSY, Joao Guilherme Pontes Lima
BERRETA, Olivia Campos Pinheiro
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, v.61, article ID UNSP e27, 5p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Trypanosoma cruzi is the causative agent of Chagas disease. Nowadays, the transmission in Brazil occurs mainly by oral ingestion of contaminated food that has been associated with more severe clinical manifestations. We report a case of Acute Chagas disease caused by oral transmission in a child from Northern Brazil. In the hospital admission, physical examination showed tachycardia, hepatomegaly. bipalpebral edema and anasarca. Trypanosoma cruzi trypomastigotes were found in microscopy during blood cell count. Twenty-three days before hospitalization, the child had ingested the ""bacaba palm fruit's wine"". Even with the appropriate diagnosis and starting of treatment, she did not survive. Quantitative analysis of Trypanosoma cruzi DNA in a blood sample resulted in 54,053.42 parasite equivalents/mL and the DTU TcIV was identified. The outcome may have been determined by several factors, including the delay to seek a medical service beyond the high parasitemia, detected by qPCR. DTU TcIV could also have influenced the natural history of the disease.
Palavras-chave
Acute Chagas disease, Trypanosoma cruzi, qPCR, Bacaba palm fruit, Children
Referências
  1. de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608
  2. Aliaga C, 2011, INFECT GENET EVOL, V11, P1155, DOI 10.1016/j.meegid.2010.11.013
  3. Barreto-de-Albuquerque J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003849
  4. Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711
  5. Brandao E, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0369-0
  6. Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2017, COORD GER DES EP SER
  7. Breniere SF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004792
  8. Ramirez JC, 2015, J MOL DIAGN, V17, P605, DOI 10.1016/j.jmoldx.2015.04.010
  9. dos Santos VRC, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170298
  10. Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5
  11. Messenger LA, 2015, EXPERT REV ANTI-INFE, V13, P995, DOI 10.1586/14787210.2015.1056158
  12. Monteiro WM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002069
  13. Nobrega AA, 2009, EMERG INFECT DIS, V15, P653, DOI 10.3201/eid1504.081450
  14. Organizacao Pan-Americana da Saude, 2009, DOENC CHAG GUIA VIG
  15. Dias JCP, 2016, REV SOC BRAS MED TRO, V49, P3, DOI 10.1590/0037-8682-0505-2016
  16. Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956
  17. Stanaway JD, 2015, GLOB HEART, V10, P139, DOI 10.1016/j.gheart.2015.06.001
  18. de Freitas VLT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001277
  19. World Health Organization, 2002, CONTR CHAG DIS 2 REP
  20. 2008, REV SOC BRAS MED TRO, V41, P602